Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Drug hypersensitivity? 43 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Drug hypersensitivity have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.1% of all adverse event reports for DABIGATRAN ETEXILATE.

43
Reports of Drug hypersensitivity with DABIGATRAN ETEXILATE
0.1%
of all DABIGATRAN ETEXILATE reports
0
Deaths
11
Hospitalizations

How Dangerous Is Drug hypersensitivity From DABIGATRAN ETEXILATE?

Of the 43 reports, 11 (25.6%) required hospitalization, and 1 (2.3%) were considered life-threatening.

Is Drug hypersensitivity Listed in the Official Label?

Yes, Drug hypersensitivity is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Drug hypersensitivity?

METHOTREXATE (16,677) ETANERCEPT (12,991) ADALIMUMAB (11,599) MORPHINE (11,095) RITUXIMAB (8,924) LEFLUNOMIDE (8,148) INFLIXIMAB (8,119) TOCILIZUMAB (7,883) ABATACEPT (7,808) CODEINE (7,479)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Drug hypersensitivity Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Drug hypersensitivity Reports All Drugs Causing Drug hypersensitivity DABIGATRAN ETEXILATE Demographics